GE Ventures and Mayo Clinic Launch Company to Scale and Digitize Cell and Gene Therapies

GE Ventures and Mayo Clinic announced the launch of Vitruvian Networks, Inc., an independent platform company committed to accelerating access to cell and gene therapies through advanced, cloud-ready software systems and manufacturing services.
According to the news:

Cell and gene therapy involve time and resource-intense processes to provide personalized therapies to patients. Efficient and cost-effective solutions are required to expedite the transition of promising and potentially curative therapies from early clinical trials to a portfolio of products that advances medical care.

Sue Siegel, CEO, GE Ventures and healthymagination stated:

Merging GE’s operational excellence with emerging cell and gene therapies will enable faster, more effective and safer treatments for patients. Mayo Clinic is a key leader in patient treatment delivery in cancer care and regenerative medicine, so we are honored to have incubated this solution in joint partnership.

Click here to view the full press release.